TextbookENTHoarseness

Hoarseness

Hoarseness (dysphonia) is a change in voice quality that can result from a wide range of conditions from benign self-limiting laryngitis to laryngeal carcinoma, requiring investigation if persisting beyond 3 weeks.

PLAB 1UKMLA0 questions

Key Facts

Hoarseness (dysphonia) is an alteration in voice quality, pitch, or volume; affects approximately 1% of the population at any time Most common cause: acute viral laryngitis (self-limiting); most important cause to exclude: laryngeal carcinoma NICE NG12: refer urgently (2-week wait) for laryngoscopy if hoarseness >3 weeks, particularly in smokers/ex-smokers >45 years Functional dysphonia is a common cause of chronic hoarseness with a structurally normal larynx — diagnosed by speech therapy assessment Vocal cord palsy causes breathy voice; investigate with CT from skull base to diaphragm to identify cause along course of vagus/recurrent laryngeal nerve Laryngopharyngeal reflux is a common cause of chronic hoarseness, throat clearing, and globus — treat with PPI (omeprazole 20mg BD for 2-3 months) Speech and language therapy is the first-line treatment for most benign causes of chronic hoarseness Key history: smoking, alcohol, voice use, reflux symptoms, previous neck/chest surgery, intubation history

Overview

Key Facts

Hoarseness is one of the most common ENT symptoms, with a wide differential diagnosis ranging from benign self-limiting conditions to life-threatening malignancy. Any patient with hoarseness persisting beyond 3 weeks requires visualisation of the larynx to exclude serious pathology.

Epidemiology

  • Point prevalence: approximately 1% of the population
  • Lifetime prevalence: 30% experience at least one episode of significant hoarseness
  • More common in professional voice users (teachers, singers)
  • Laryngeal cancer: approximately 2,400 cases/year in the UK; M:F ratio 4:1

Aetiology

  • Inflammatory: acute viral laryngitis (most common overall), chronic laryngitis, laryngopharyngeal reflux
  • Structural: vocal cord nodules, polyps, cysts, Reinke oedema, papillomatosis, laryngeal carcinoma
  • Neurological: vocal cord palsy (recurrent laryngeal nerve palsy — causes include lung cancer, thyroid surgery, aortic aneurysm, idiopathic)
  • Functional: muscle tension dysphonia, psychogenic aphonia
  • Systemic: hypothyroidism, RA (cricoarytenoid arthritis), amyloidosis
  • Iatrogenic: post-intubation granuloma, post-thyroidectomy RLN injury, inhaled corticosteroid effect

Pathophysiology

  • Normal voice production requires: adequate subglottic air pressure, regular vocal cord vibration, and normal resonance
  • Any disruption to vocal cord structure, mass, tension, or mobility causes hoarseness
  • Mass lesions (nodules, polyps, tumours) increase vocal cord mass and alter vibration
  • Vocal cord palsy prevents full cord adduction, causing breathy voice and air escape
  • Oedema (Reinke oedema, reflux) deepens the voice due to increased cord mass

Clinical Presentation

History Points

  • Duration and onset (acute vs chronic)
  • Character of voice change (rough, breathy, strained, weak)
  • Associated symptoms: sore throat, dysphagia, odynophagia, otalgia, stridor, cough, haemoptysis, weight loss
  • Voice demands: professional voice user
  • Smoking and alcohol history (strong risk factors for laryngeal cancer)
  • Reflux symptoms: heartburn, throat clearing, globus, chronic cough
  • Previous surgery: thyroidectomy, cardiac, thoracic, anterior cervical spine
  • Previous intubation
  • Medications: inhaled corticosteroids, ACE inhibitors (cough)

Examination

  • Voice quality assessment
  • Neck palpation: thyroid, lymphadenopathy
  • Oral cavity and oropharynx inspection
  • Indirect laryngoscopy or fibreoptic nasendoscopy

Red Flags

  • Hoarseness >3 weeks (NICE NG12)
  • Smoker/ex-smoker >45 years
  • Dysphagia or odynophagia
  • Haemoptysis
  • Stridor
  • Weight loss
  • Neck lump
  • Otalgia (referred pain from larynx via Arnold's nerve)

Differential Diagnosis

DiagnosisKey FeaturesInvestigation
Acute viral laryngitisShort history, URTI, self-limitingClinical
Laryngeal carcinomaSmoker, progressive, weight loss, dysphagiaFNL, CT, biopsy
Vocal cord nodulesBilateral, voice abuse, young female/childFNL, stroboscopy
Vocal cord palsyBreathy voice, aspiration; investigate RLNFNL, CT skull base to diaphragm
Laryngopharyngeal refluxThroat clearing, globus, chronic coughPPI trial, 24h pH
Functional dysphoniaNormal larynx, psychosocial factorsFNL, SLT assessment
Reinke oedemaDeep voice, smoker, bilateral polypoid cordsFNL
HypothyroidismCoarse voice, fatigue, weight gain, constipationTFTs

Diagnosis / Investigation

Bedside

  • GRBAS voice assessment
  • Neck examination (lymph nodes, thyroid)
  • Fibreoptic nasendoscopy (FNL): essential for all hoarseness >3 weeks

Bloods

  • TFTs (exclude hypothyroidism)
  • FBC if anaemia/malignancy suspected

Imaging

  • CT neck and chest (skull base to diaphragm): for vocal cord palsy (identify cause along nerve course)
  • CT with contrast: for laryngeal masses and staging
  • MRI: for soft tissue detail of laryngeal/hypopharyngeal lesions
  • CXR: if vocal cord palsy (exclude left hilar mass)

Special Tests

  • Stroboscopy: detailed assessment of vocal cord vibration pattern
  • Direct laryngoscopy and biopsy (under GA): for suspicious lesions
  • Laryngeal EMG: for vocal cord palsy (prognostication)
  • 24h pH/impedance monitoring: for laryngopharyngeal reflux
  • SALT assessment: for functional voice disorders

Management

Non-pharmacological

  • Voice rest and vocal hygiene: reduce voice use, avoid whispering (increases cord tension)
  • Hydration
  • Avoid irritants (smoking, alcohol)
  • Speech and language therapy (SALT): first-line for functional dysphonia, vocal cord nodules, muscle tension dysphonia

Pharmacological

  • PPI trial for suspected laryngopharyngeal reflux: omeprazole 20mg BD for 2-3 months
  • Topical antifungal if inhaled corticosteroid-related candidiasis
  • Levothyroxine if hypothyroidism confirmed
  • Treat underlying cause (cancer, infection, reflux)

Surgical

  • Microlaryngoscopy and excision: for vocal cord polyps, cysts, papillomatosis, suspicious lesions/biopsy
  • Medialization thyroplasty: for permanent unilateral vocal cord palsy (implant pushes paralysed cord medially)
  • Injection laryngoplasty: temporary medialization with hyaluronic acid or autologous fat for vocal cord palsy
  • Laryngeal framework surgery: for bilateral cord palsy (tracheostomy may be needed if airway compromise)
  • Treatment of malignancy: radiotherapy (early glottic), surgery (partial/total laryngectomy), chemoradiotherapy

Referral Criteria

  • 2-week wait ENT referral: hoarseness >3 weeks (NICE NG12)
  • Routine ENT: chronic voice change, globus, frequent throat clearing
  • Emergency: stridor, airway compromise
  • SALT referral: for voice rehabilitation

Prognosis

  • Acute laryngitis: resolves within 7-10 days
  • Vocal cord nodules: >80% resolve with speech therapy
  • Vocal cord palsy: spontaneous recovery in 50-60% of idiopathic cases within 6-12 months
  • Early glottic carcinoma (T1): >90% 5-year survival with radiotherapy
  • Functional dysphonia: responds well to SALT; prognosis good
  • Reinke oedema: improves with smoking cessation; surgery if persistent
  • Post-thyroidectomy RLN palsy: temporary in 5-10%, permanent in 1-2%

Other Relevant Information

Approach to Hoarseness >3 Weeks

StepAction
1History: smoking, alcohol, voice use, reflux, surgery, meds
2Neck examination
3Fibreoptic nasendoscopy
4If normal: PPI trial, SALT referral
5If abnormal: biopsy, CT/MRI, MDT

Key Causes of Vocal Cord Palsy and Investigation

Cause%Key Investigation
Iatrogenic (surgery)30-40%Surgical history
Malignancy (lung, thyroid)20-30%CT chest/neck
Idiopathic20-30%Diagnosis of exclusion
Neurological (MS, stroke)5%MRI brain
Aortic aneurysmRareCT chest